5 completed, 2 withdrawn. 6 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Withdrawn 2 |
| Phase 1 | 1 | Completed 1 |
Follow Polichem S.A.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s P-3073 (calcipotriene 0.005%), Vehicle of P-3073 - Nail Psoriasis | Phase 3 | Withdrawn | Polichem S.A. | 2017-05-15 | 2018-01-10 | |
| Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis P-3058 (terbinafine hydrochloride 10%), Vehicle of P-3058 - Onychomycosis of Toenail | Phase 3 | Withdrawn | Polichem S.A. | 2017-05-01 | 2018-01-10 | |
| Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia P-3074, Finasteride, P-3074 Vehicle - Alopecia, Androgenetic | Phase 3 | Completed | Polichem S.A. | 458 | 2016-08-02 | 2019-06-20 |
| Photosensitization Study in Androgenetic Alopecia Finasteride 0.25%, Placebo for Finasteride 0.25%, Negative Control - Androgenetic Alopecia | Phase 1 | Completed | Polichem S.A. | 58 | 2016-05-09 | 2017-05-18 |
| Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by Psoriasis P-3073, Vehicle of P-3073 - Nail Psoriasis | Phase 3 | Completed | Polichem S.A. | 378 | 2015-11-23 | 2018-03-08 |
| Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis P-3058 10%, vehicle of P-3058 10%, amorolfine 5% - Onychomycosis | Phase 3 | Completed | Polichem S.A. | 953 | 2015-08-20 | 2018-09-26 |
| Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population P-3058 - Onychomycosis | Phase 3 | Completed | Polichem S.A. | 20 | 2014-08-01 | 2018-03-08 |
Alopecia (2) · Onychomycosis (2)
Finasteride (1) · amorolfine (1)
Germany (4) · Belgium (3) · Latvia (3) · Russia (3) · Bulgaria (2) · Czechia (2) · Greece (2) · Hungary (2) · Poland (2) · Spain (2) · United States (2) · Canada (1) · Iceland (1) · Italy (1) · Lithuania (1)
Maurizio Caserini, MD (5) · Eric Massana, MD (1) · Michael Carr, MD (1)
2015 (2)